Major improvement of the reference method of the French drug resistance network for P-glycoprotein detection in human haematological malignancies

Leukemia Research

Volumn 29, Issue 9, 2005, Pages 1029-1037

  Huet, Sylvie ^a   Marie, Jean Pierre ^b   Laurand, Armelle ^a   Robert, Jacques ^a  

^a INSTITUT BERGONIÉ   (France)

^b INSERM   (France)

Author keywords

Flow cytometry; Haematological malignancies; P glycoprotein

Indexed keywords

FLUORESCEIN; GLYCOPROTEIN P; PHYCOERYTHRIN; PROPIDIUM IODIDE;

ARTICLE; BLOOD CELL; CONTROLLED STUDY; CYTOLYSIS; DENSITY GRADIENT; ERYTHROCYTE; FLOW CYTOMETRY; GRANULOCYTE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; INCUBATION TIME; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HEMATOLOGIC NEOPLASMS; HUMANS; P-GLYCOPROTEIN; REFERENCE STANDARDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 22144468786     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.02.011     Document Type: Article

References (50)

1. S. Huet, J.P. Marie, N. Gualde, and J. Robert Reference method for detection of Pgp mediated multidrug resistance in human hematological malignancies: a method validated by the laboratories of the French Drug Resistance Network Cytometry 34 1998 248 256
2. J.P. Marie, S. Huet, A.M. Faussat, J.Y. Perrot, S. Chevillard, and V. Barbu Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hopitaux de Paris Leukemia 11 1997 1086 1094
3. W.T. Beck, T.M. Grogan, C.L. Willman, C. Cordon-Cardo, D.M. Parham, and J.F. Kuttesch Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations Cancer Res 56 1996 3010 3020
4. W.T. Beck, and T.M. Grogan Methods to detect P-glycoprotein and implications for other drug resistance-associated proteins Leukemia 11 1997 1107 1109
5. H.J. Broxterman, J. Lankelma, H.M. Pinedo, C.A. Eekman, D.C. Wahrer, and G.J. Ossenkoppele Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemia Leukemia 11 1997 1110 1118
6. P. Maslak, S. Hegewisch-Becker, L. Godfrey, and M. Andreeff Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia Cytometry 17 1994 84 93
7. P. Baines, M. Limaye, T. Hoy, R.A. Padua, J. Whittaker, and A. al Sabah In vitro drug resistance in acute myeloid and chronic B-lymphocytic leukaemic blasts and in normal blood and marrow populations Leuk Res 18 1994 683 691
8. J.L. Merlin, A. Guerci, S. Marchal, N. Missoum, C. Ramacci, and J.C. Humbert Comparative evaluation of S9788, verapamil, and cyclosporine A in K562 human leukemia cell lines and in P-glycoprotein-expressing samples from patients with hematologic malignancies Blood 84 1994 262 269
9. T. Ino, H. Miyazaki, M. Isogai, T. Nomura, M. Tsuzuki, and T. Tsuruo Expression of P-glycoprotein in de novo acute myelogenous leukemia at initial diagnosis: results of molecular and functional assays, and correlation with treatment outcome Leukemia 8 1994 1492 1497
10. A. Guerci, J.L. Merlin, N. Missoum, L. Feldmann, S. Marchal, and F. Witz Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry Blood 85 1995 2147 2153
11. A. Takeshita, K. Shinjo, K. Ohnishi, and R. Ohno New flow cytometric method for detection of minimally expressed multidrug resistance P-glycoprotein on normal and acute leukemia cells using biotinylated MRK16 and streptavidin-RED670 conjugate Jpn J Cancer Res 86 1995 607 615
12. E. Wattel, P. Lepelley, A. Merlat, C. Sartiaux, F. Bauters, and J.P. Jouet Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment Leukemia 9 1995 1870 1874
13. R. Longo, L. Bensi, A. Vecchi, C. Messora, and S. Sacchi P-glycoprotein expression in acute myeloblastic leukemia analyzed by immunocytochemistry and flow cytometry Leuk Lymphoma 17 1995 121 125
14. X.Y. Xie, D. Robb, S. Chow, and D.W. Hedley Discordant P-glycoprotein antigen expression and transport function in acute myeloid leukemia Leukemia 9 1995 1882 1887
15. C.P. Leith, I.M. Chen, K.J. Kopecky, F.R. Appelbaum, D.R. Head, and J.E. Godwin Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases Blood 86 1995 2329 2342
16. A. Tafuri, A. Sommaggio, L. Burba, M.P. Albergoni, M.T. Petrucci, and M.G. Mascolo Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia Leuk Res 19 12 1995 927 931
17. T. Lamy, B. Drenou, I. Grulois, O. Fardel, C. Jacquelinet, and J. Goasguen Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay Leukemia 9 1995 1549 1555
18. A.G. Turkina, A.Y. Baryshnikov, N.P. Sedyakhina, S.V. Folomeshkina, M.A. Sokolova, and N.D. Choroshco Studies of P-glycoprotein in chronic myelogenous leukaemia patients: expression, activity and correlations with CD34 antigen Br J Haematol 92 1996 88 96
19. H.J. Broxterman, P. Sonneveld, N. Feller, G.J. Ossenkoppele, D.C. Wahrer, and C.A. Eekman Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity Blood 87 1996 4809 4816
20. A. Takeshita, K. Shinjo, K. Ohnishi, and R. Ohno Expression of multidrug resistance P-glycoprotein in myeloid progenitor cells of different phenotype: comparison between normal bone marrow cells and leukaemia cells Br J Haematol 93 1996 18 21
21. G. Del Poeta, A. Venditti, R. Stasi, G. Aronica, M.C. Cox, and F. Buccisano P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia Leuk Res 23 1999 451 465
22. G. Del Poeta, R. Stasi, G. Aronica, A. Venditti, M.C. Cox, and A. Bruno Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia Blood 87 1996 1997 2004
23. S.P. Ivy, R.S. Olshefski, B.J. Taylor, K.M. Patel, and G.H. Reaman Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study Blood 88 1996 309 318
24. B. Drenou, T. Lamy, L. Amiot, O. Fardel, S. Caulet-Maugendre, and M. Sasportes CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance Blood 89 1997 2966 2974
25. M. Pallis, Y.M. Zhu, and N.H. Russell Bcl-x(L) is heterogenously expressed by acute myeloblastic leukaemia cells and is associated with autonomous growth in vitro and with P-glycoprotein expression Leukemia 11 1997 945 949
26. M.L. den Boer, R. Pieters, K.M. Kazemier, G.E. Janka-Schaub, G. Henze, and A.J. Veerman The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia Leukemia 12 1998 912 920
27. M.L. den Boer, C.M. Zwaan, R. Pieters, K.M. Kazemier, M.M. Rottier, and M.J. Flens Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia Leukemia 11 1997 1078 1085
28. M.L. den Boer, P. Kapaun, R. Pieters, K.M. Kazemier, G.E. Janka-Schaub, and A.J. Veerman Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance Br J Haematol 105 1999 876 882
29. S. Kasimir-Bauer, H. Ottinger, P. Meusers, D.W. Beelen, G. Brittinger, and S. Seeber In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapy Exp Hematol 26 1998 1111 1117
30. D. Damiani, M. Michieli, A. Ermacora, A. Candoni, D. Raspadori, and A. Geromin P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias Haematologica 83 1998 290 297
31. M. Pallis, J. Turzanski, S. Langabeer, and N.H. Russell Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts Adv Exp Med Biol 457 1999 77 88
32. M. Pallis, J. Turzanski, G. Harrison, K. Wheatley, S. Langabeer, and A.K. Burnett Use of standardised flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia Br J Haematol 104 1999 307 312
33. H.J. Broxterman, P. Sonneveld, R. Pieters, J. Lankelma, C.A. Eekman, and A.H. Loonen Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia? Leukemia 13 1999 258 265
34. C.P. Leith, K.J. Kopecky, I.M. Chen, L. Eijdems, M.L. Slovak, and T.S. McConnell Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study Blood 94 1999 1086 1099
35. C. Wuchter, K. Leonid, V. Ruppert, M. Schrappe, T. Buchner, and C. Schoch Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia Haematologica 85 2000 711 721
36. U. Tidefelt, J. Liliemark, A. Gruber, E. Liliemark, B. Sundman-Engberg, and G. Juliusson P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemia J Clin Oncol 18 2000 1837 1844
37. M.R. Muller, K. Lennartz, B. Baack, M.M. Heim, S. Seeber, and M.E. Scheulen Simultaneous measurement of cellular P-glycoprotein content and function by multiparametric flow-cytometry Int J Clin Pharmacol Ther 38 2000 180 186
38. R. Dorr, C. Karanes, C. Spier, T. Grogan, J. Greer, and J. Moore Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia J Clin Oncol 19 2001 1589 1599
39. M.M. van den Heuvel-Eibrink, E.A. Wiemer, M.J. de Boevere, H.B. van der, P.J. Vossebeld, and R. Pieters MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia Blood 97 2001 3605 3611
40. E. Tothova, A. Elbertova, M. Fricova, A. Kafkova, M. Hlebaskova, and E. Svorcova P-glycoprotein expression in adult acute myeloid leukemia: correlation with induction treatment outcome Neoplasma 48 2001 393 397
41. A.M. Tsimberidou, G. Paterakis, G. Androutsos, N. Anagnostopoulos, A. Galanopoulos, and T. Kalmantis Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia Leuk Res 26 2002 143 154
42. Y. Umeda, K. Yamauchi, I. Sugawara, S. Arimori, and T. Nagao Relationship between expression of P-glycoprotein and use of noncytotoxic drug before chemotherapy in acute leukaemia Cancer J 7 1994 39 43
43. E.B. Mechetner, and I.B. Roninson Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody Proc Natl Acad Sci USA 89 1992 5824 5828
44. T. Shi, J. Wrin, J. Reeder, D. Liu, and D.B. Ring High-affinity monoclonal antibodies against P-glycoprotein Clin Immunol Immunopathol 76 1995 44 51
45. M. Poot, L.L. Gibson, and V.L. Singer Detection of apoptosis in live cells by MitoTracker red CMXRos and SYTO dye flow cytometry Cytometry 27 1997 358 364
46. D.C. Zhou, S. Ramond, F. Viguie, A.M. Faussat, R. Zittoun, and J.P. Marie Sequential emergence of MRP- and MDR1-gene over-expression as well as MDR1-gene translocation in homoharringtonine-selected K562 human leukemia cell lines Int J Cancer 65 1996 365 371
47. S. Huet, B. Schott, and J. Robert P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lines Br J Cancer 65 1992 538 544
48. Y.P. Hu, P. Pourquier, F. Doignon, M. Crouzet, and J. Robert Effects of modulators of multidrug resistance on the expression of the MDR1 gene on human KB cells in culture Anticancer Drugs 7 1996 738 744
49. K.E. Noonan, C. Beck, T.A. Holzmayer, J.E. Chin, J.S. Wunder, and I.L. Andrulis Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction Proc Natl Acad Sci USA 87 1990 7160 7164
50. F. Lacombe, F. Durrieu, and P. Briais Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia Leukemia 11 1997 1878 1886